23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
2024年1月31日 - 12:12PM
23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic
health and biopharmaceutical company, announced a month-long
initiative to amplify Ava DuVernay’s new film ORIGIN and the film’s
groundbreaking Seat16 program. Seat16 allows anyone to gift
$16 or more to purchase an ORIGIN movie ticket for a young person
who might not otherwise be able to purchase a ticket to the film.
For 23 days, 23andMe will donate 100 seats daily to support the
program.
ARRAY, the multi-platform arts and social impact collective
founded by Ava DuVernay, created the Seat16 initiative to ensure
that 10,000 young people across the nation get to experience
ORIGIN.
Written, directed, and produced by Academy Award nominee Ava
DuVernay, ORIGIN explores the mystery of history, the wonders of
romance, and a fight for our future. While investigating the global
phenomenon of caste and its dark influence on society, a journalist
faces unfathomable personal loss and uncovers the beauty of human
resilience. With an expansive cast that includes Academy Award
nominee Aunjanue Ellis-Taylor, Jon Bernthal, and Niecy Nash-Betts,
the film was inspired by Pulitzer Prize-winning journalist Isabel
Wilkerson's novel Caste: The Origin of Our Discontents.
“It’s a scientific fact we are all 99.5 percent genetically
identical. We are more alike than we are different and sometimes
people forget humans have created hierarchies and caste systems. As
a brand we focus on the knowledge that we are all connected,
equally, through our DNA,” said Tracy Keim, Chief Brand Officer at
23andMe. “Supporting Ava DuVernay, ARRAY and the ORIGIN team by
purchasing tickets for young adults through their Seat 16 program,
encourages a new generation to have the opportunity to be educated
through the film’s storytelling about our connection, not our
differences.”
View the film's trailer here. Through her foundation, 23andMe
co-founder and CEO Anne Wojcicki helped fund the film along with
several other non-profits.
About 23andMe23andMe is a genetics-led consumer
healthcare and biopharmaceutical company empowering a healthier
future. For more information, please
visit www.23andMe.com.
ContactsMedia
Contact: press@23andMe.com
23andMe (NASDAQ:ME)
過去 株価チャート
から 5 2024 まで 6 2024
23andMe (NASDAQ:ME)
過去 株価チャート
から 6 2023 まで 6 2024